A sweet tribute to Dr. Mechoulam, the father of the endocannabinoid system, by Dr. Maccarrone
Tribute to Professor Raphael Mechoulam, The Founder of Cannabinoid and Endocannabinoid Research
A free lecture by the famed Dr. Allyn Howlett (discoverer of the CB1 receptor) on targeting the endocannabinoid system
Best of the Week...
And now for the paper that’s been blowing up online, CBGA & CBDA block the entry of the COVID virus into epithelial cells
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
Interview with the researcher
We are pleased to see the new preclinical study about CBDA & CBGA preventing cellular infiltration by SARS-CoV-2 but we do caution that these results occurred in human cells, not humans, and that it is not easy to covert the milligrams of the doses used.
Luckily, both Jimmy Kimmel & Stephen Colbert present their scientific take on these findings
In cells, CBD helped to augment the anti-viral response that would be raised against SARS-CoV-2
Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
This review suggests β-Caryophyllene (the most common terpene in the plant) as a natural treatment for COVID-19
β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
A review of using the cannabinoids for COVID-19
Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
A study in 28k people found that CBD did not find any association with negative liver function
Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults
In humans with peripheral neuropathy, a double-blind study showed topical CBD oil caused “significant improvement in pain and other disturbing sensations”
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
In rats with a systemic inflammatory response, “CBD treatment significantly improved behavioral tasks and decreased the level of inflammatory cytokines”
Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats
This survey shows that most women who used cannabis or cannabinoids (THC, CBD, PEA) for gynecologic conditions found that it improved pain
Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review
Clinical Studies & Reviews of CBD & the Endocannabinoid System (ECS)
In humans with gliomas (the most aggressive brain cancer), a nightly dose of THC “improved sleep, functional wellbeing, and quality of life”
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
2011: In humans with cancer experiencing poor appetite as well as diminished taste & smell, 2.5 mg of THC made their food taste better, increased the calories consumer & increased sleep quality & relaxation
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
A review of using cannabis for autoimmune disorders
Cannabis and Autoimmunity: Possible Mechanisms of Action
This review finds THC & CBD helpful for the symptoms of kidney failure
Cannabinoids for Symptom Management in Patients with Kidney Failure
This survey finds that consumers use topical cannabis for treating skin conditions like acne & psoriasis
Consumer Perspectives on and Utilization of Medical Cannabis to Treat Dermatologic Conditions
A review of CBD in edibles
Benefits, toxicity and current market of cannabidiol in edibles
A review of CBD for cosmetology & dermatology
Cannabidiol – characteristic and application in cosmetology and dermatology
In humans, a look at the pharmacology of taking Spectrum Red softgels (2.5 mg THC, ~.25 mg CBD)
Safety, Pharmacokinetics, and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants
In humans with Tourette syndrome, a MAGL inhibitor (which raises 2-AG levels) caused tic reduction with just a single dose
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study
It is suggested, but not confirmed, that CBD also reduces MGL degradation of 2-AG.
This review looks at how the cannabinoids regulate the olfactory & visual sensory circuits
Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits
This review highlights the ability of CBN to protect the mitochondria (powerhouse of the cell) by regulating oxytosis/ferroptosis (oxidative stress pathway)
Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors
Preclinical Research & Cannabinoid Chemistry
In a mouse model of peanut allergies, an activator of the CB1 receptor reduced immune system activation & promoted a healthy response
The cannabinoid WIN55212-2 impairs peanut allergic sensitization and promotes the generation of allergen-specific regulatory T cells
In white blood cells infected by HIV, activating the CB2 receptor reduced neurotoxicity
Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages
In rats, effects of sex, species & age on pharmacology of THC
Sex, species and age: Effects of rodent demographics on the pharmacology of ∆ 9-tetrahydrocanabinol
The main finding is that THC’s effects are stronger in females.
Comments